IP Library Granted Patent US 12,059,447
Granted Patent B2
US 12,059,447 · App. 16/988,627 · Granted Aug 13, 2024

Olfactory delivery of therapeutic compounds to the central nervous system

Inventors: Sean Farmer (North Miami beach, FL); Ken Alibek (Solon, OH)
Assignee: LOCUS SOLUTIONS IPCO, LLC
A61K36/53A61K9/0043A61K9/0075A61K9/0078A61K47/10A61K47/183
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,059,447
App. No.
16/988,627
Granted
Aug 13, 2024
Kind
B2
Abstract

The present invention provides materials and methods for treating symptoms of neurological conditions. More specifically, the subject invention provides compositions and methods of their use for treating one or more symptoms and/or comorbidities of a neurological condition such as an infection, a neurodevelopmental disease, and/or a neurodegenerative disease. In preferred embodiments, the composition is administered to the subject via nasal administration.

Claims (11)

1. A method for treating neurological inflammation, the method comprising, administering, via the nasal cavity, a composition comprising a sophorolipid, a mannosylerythritol lipid, and an antioxidant, to a subject in need of such treatment, wherein the sophorolipid and the mannosylerythritol lipid are in the form of a liposome and the antioxidant is encased in the liposome, and

wherein the neurological inflammation is caused by head trauma, a brain tumor, an allergic reaction, a neurodegenerative disease, or an infection.

2. The method of claim 1 , wherein administration is carried out using a syringe, dropper, pump action nasal spray, nebulizer, atomizer, and/or an exhalation powered nasal device.

3. The method of claim 1 , wherein the composition is administered to the subject 4 or 5 times daily.

4. The method of claim 1 , wherein the composition further comprises glycerol and/or glycerin as a smoothing agent.

5. The method of claim 1 , wherein the composition further comprises a salt as an emulsifier.

6. The method of claim 1 , wherein the composition is formulated as a liquid or a powder.

7. The method of claim 1 , wherein the composition is administered via the nasal cavity at a total volume of 0.01 ml to 5 ml per dose.

8. The method of claim 1 , wherein the neurological inflammation is caused by a neurodegenerative disease.

9. The method of claim 1 , wherein the antioxidant is N-acetyl-L-cysteine.

10. The method of claim 1 , wherein the composition further comprises at least one plant extract or essential oil selected from the group consisting of eucalyptus oil, clove oil, and tea tree oil.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Nov 18, 2024
From: U.S. BANK TRUST COMPANY
To: LOCUS SOLUTIONS, LLC; LOCUS MANAGEMENT GP, INC.; LOCUS MANAGEMENT, LLC; LOCUS IP COMPANY, LLC; LOCUS OIL HOLDING, LLC,; LOCUS BIO-ENERGY SOLUTIONS, LLC; LOCUS OIL IP COMPANY, LLC; LOCUS AGRICULTURE HOLDING, LLC; LOCUS AGRICULTURAL SOLUTIONS, LLC; LOCUS AGRICULTURE IP COMPANY, LLC,; LOCUS SOLUTIONS IPCO, LLC; LOCUS SOLUTIONS IPHOLDCO, LLC; LOCUS CONSUMER BRANDS HOLDING, LLC; ARCTIVA WELLNESS, LLC
Reel/Frame 069386/0272 →
SECURITY INTEREST Recorded Nov 11, 2024
From: LOCUS SOLUTIONS IPCO, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 069333/0911 →
RELEASE OF SECURITY INTEREST Recorded Oct 30, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 069273/0361 →
SECURITY INTEREST Recorded Dec 8, 2023
From: LOCUS SOLUTIONS IPCO, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 065836/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2023
From: LOCUS IP COMPANY, LLC
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 065615/0905 →
SECURITY INTEREST Recorded Dec 7, 2022
From: LOCUS SOLUTIONS, LLC; LOCUS MANAGEMENT GP, INC.; LOCUS MANAGEMENT, LLC; LOCUS IP COMPANY, LLC; LOCUS OIL HOLDING, LLC; LOCUS BIO-ENERGY SOLUTIONS, LLC; LOCUS OIL IP COMPANY, LLC; LOCUS AGRICULTURE HOLDING, LLC; LOCUS AGRICULTURAL SOLUTIONS, LLC; LOCUS AGRICULTURE IP COMPANY, LLC; LOCUS SOLUTIONS IPCO, LLC; LOCUS SOLUTIONS IPHOLDCO, LLC; LOCUS CONSUMER BRANDS HOLDING, LLC; ARCTIVA WELLNESS, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062079/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2022
From: LOCUS IP COMPANY, LLC
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 062054/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2022
From: FARMER, SEAN; ALIBEK, KEN
To: LOCUS IP COMPANY, LLC
Reel/Frame 060843/0742 →
Continuity (2)
Provisional Application 62885231 · Aug 10, 2019
Related Publication 20210038671A1 · Feb 11, 2021